🔎 Trials Near Me

Akèy › Limfom › Pennsylvania › Pittsburgh

Etid klinik pou Limfom nan Pittsburgh, PA

10 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Ap rekriteFaz 2
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07221500

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon
  • University of Pittsburgh Medical Center, Pittsburgh
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Ap rekriteFaz 1/2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
12 Months – 21 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT04870944

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • West Penn Hospital, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3
  • Allegheny Health Network, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Allegheny Health Network Cancer Institute, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Ap rekriteFaz 1/2
  • Dren Investigational Site 2, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT05475925

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • UPMC Hilman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • University of Pittsburgh Medical Center (UPMC), Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2025 · NCT04234048

Etid Limfom nan lòt vil

Lòt etid nan Pittsburgh

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.